PULMATRIX, INC. Payments of Financing Costs
PULMATRIX, INC. (PULM) reported Payments of Financing Costs of $0 for the 9-month period ending 2014-12-31, per its 10-Q filed 2015-02-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2015-02-13
- PULMATRIX, INC. payments of financing costs for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
- PULMATRIX, INC. payments of financing costs for the quarter ending 2014-09-30 was $0.00, a 100.00% decline year-over-year.
- PULMATRIX, INC. payments of financing costs for the quarter ending 2014-06-30 was $0.00, a 100.00% decline year-over-year.
- PULMATRIX, INC. payments of financing costs for the quarter ending 2013-12-31 was $336.00K.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month |
|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-13 | $0.00 derived: sum of 2 quarters · filed 2015-02-13 | $0.00 10-Q · filed 2015-02-13 |
| 2014-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-13 | $0.00 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-14 | ||
| 2013-12-31 | $336.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-13 | $607.00K derived: sum of 2 quarters · filed 2015-02-13 | $1.12M 10-Q · filed 2015-02-13 |
| 2013-09-30 | $271.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-13 | $780.00K 10-Q · filed 2014-11-13 | |
| 2013-06-30 | $509.00K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |